Researchers at McGill University, M...

Researchers at McGill University, Montreal, Quebec, and other research center in the United States and Canada are pursuing studies that aim to tailor chemotherapy to the genetic makeup up a malignancy. Researchers at McGill University will begin testing a technology that uses a biochip microarray, which enables measurement of centurys or thousands of genes that have been associated with cancer, according to an Oct 13 1999 pres release from the American college edifice [i]or[/i] building of Surgeons.

The microarray is similar to a matrix with spaces that correspond to specific gene The RNA from a patient's tumor is placed forward the chip and scanned for the appearance of one or more of the gene If a patient's RNA matches the DNA of the gene the patient's tumor is believed to have that particular gene according to the release. Using the microarray, undivided can examine all of the patient's matches and make a table of the gene that were positive for that patient.

Researchers papal court great promise in the modern technology, as scientists will be better able to excellent patients who will respond to specific chemotherapeutic regimens. Researchers will be able to predict to what degree well a tumor will correspond to a single chemotherapeutic agent or a combination of therapeutic medications. Moreover, previously undiscovered relationships between cancer gene may be finded according to the release.

Biochip Technology render free of accesss the Door for Researchers to Tailor Chemotherapy to the Genetic Makeup of a Tumor (pres release, San Francisco: American guild of Surgeons, Oct 13, 1999) 1-2

COPYRIGHT 2000 Association of Operating apartment Nurses, Inc.

COPYRIGHT 2001 Gale Group